NCT07347366 Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration
| NCT ID | NCT07347366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pusan National University Yangsan Hospital |
| Condition | Sputum |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-09-23 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-09-23 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This exploratory study aims to evaluate the efficacy and safety of an electromagnetic high-frequency, low-strain chest wall oscillation device for enhancing pulm
Eligibility Criteria
Inclusion Criteria: * Hospitalized patients who require sputum clearance. * Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the clinician to require sputum clearance. * Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized representative Exclusion Criteria: * Patients with severe pneumonia requiring intensive care unit (ICU) treatment. * Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer. * Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg). * Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or higher). * Patients hospitalized for head and neck trauma whose surgical site has not yet healed. * Patients with serious cardiac arrhythmias or hemodynamic instability. * Patients who have had pneumothorax or massive hemoptysis within the past 6 months, or who currently have hemoptysis. * Patients who have undergone spinal surgery within the past 6 months or who have acute spinal injury. * Patients with osteoporosis. * Patients with bronchopleural fistula. * Pregnant or breastfeeding women. * Patients diagnosed with cervical disc disease. * Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months (however, patients enrolled in chronic lung disease cohort studies such as asthma or COPD are allowed). * Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07347366 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sputum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07347366 currently recruiting?
Yes, NCT07347366 is actively recruiting participants. Contact the research team at zisoo@pusan.ac.kr for enrollment information.
Where is the NCT07347366 trial being conducted?
This trial is being conducted at Yangsan, South Korea.
Who is sponsoring the NCT07347366 clinical trial?
NCT07347366 is sponsored by Pusan National University Yangsan Hospital. The trial plans to enroll 45 participants.